John Sperzel

John Sperzel

Plus aucun poste en cours

Fortune : - $ au 31/05/2026

62 ans
Health Technology
Consumer Services

Profil

John J.
Sperzel
formerly worked at Chembio Diagnostics, Inc., as President, Chief Executive Officer & Director from 2014 to 2017, Chembio Diagnostics, Inc., as President, CEO & Independent Director from 2014 to 2020, ITC Nexus Holding Co., Inc., as Chief Executive Officer from 2011 to 2013, Chembio Diagnostic Systems, Inc., as President, Chief Executive Officer & Director, International Technidyne Corp., as President & Chief Executive Officer from 2011 to 2013, T2 Biosystems, Inc., as Chairman, President & Chief Executive Officer from 2021 to 2025, Diadexus, Inc., as Director, Ontera, Inc., as Director, Bayer Diagnostics Corp., as President-Marketing & Business Development from 2000 to 2009, Axis-Shield Ltd., as President-USA, and Roche Diagnostics Corp., as Vice President from 1987 to 1997.
Mr. Sperzel received his undergraduate degree from Plymouth State University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
07/01/2025 400 ( 0 % ) 0 $ 31/05/2026

Anciens postes connus de John Sperzel

SociétésPosteFin
T2 BIOSYSTEMS, INC. Directeur Général 31/03/2025
CHEMBIO DIAGNOSTICS, INC. Directeur Général 09/01/2020
CHEMBIO DIAGNOSTICS, INC. Directeur Général 30/05/2017
Directeur Général 01/12/2013
Directeur Général 01/12/2013
Voir l'expérience en détail de John Sperzel

Formation de John Sperzel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

43

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. John Sperzel
🔇